Global Drug Discovery Market 2020-2030 by Drug Type (Small Molecule, Biologics), Service (Medicinal, Biological, DMPK), Process, Technology, Therapeutic Area, End User, and Region:
(Excel Data Sheet: $2,000)
The report cover may be different from the image shown.
- The product will be delivered as a PDF file by Email within 48 business hours upon receiving an order.
- To learn more about the report, please Download Free Sample Pages and Download Excel Datasheet Sample. The report will be updated before delivery, so that the most recent historic year is the base year and forecast covers 5-10 years over the base year.
- Please Contact Us for any question, custom research, and current discount. It is possible now to buy a part of the report such as chapters, sections, data tables or figures.
By clicking the Add to Shopping Cart button, you certify to agree with our Terms of Service.
Global drug discovery market will reach $117.6 billion by 2030, growing by 8.6% annually over 2020-2030 driven by the rising demand for specialty medicines, the surge in lifestyle-oriented diseases and the advancements in technology, the growing elderly population and the rising healthcare expenses, rising expenditure on R&D, and expiration of patents.
Highlighted with 86 tables and 97 figures, this 181-page report “Global Drug Discovery Market 2020-2030 by Drug Type (Small Molecule, Biologics), Service (Medicinal, Biological, DMPK), Process, Technology, Therapeutic Area, End User, and Region: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire global drug discovery market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2017-2019 and provides estimate for 2020 and forecast from 2021 till 2030 with 2019 as the base year (Year 2020 is not appropriate for research base due to the outbreak of COVID-19).
In-depth qualitative analyses include identification and investigation of the following aspects:
• Market Structure
• Growth Drivers
• Restraints and Challenges
• Emerging Product Trends & Market Opportunities
• Porter’s Fiver Forces
The trend and outlook of global market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19. The balanced (most likely) projection is used to quantify global drug discovery market in every aspect of the classification from perspectives of Drug Type, Service, Process, Technology, Therapeutic Area, End User, and Region.
Based on Drug Type, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2019-2030 included in each section.
• Small Molecule Drugs
• Biologic Drugs
Based on Service, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2019-2030 included in each section.
• Medicinal Chemical Services
• Biological Services
• Drug Metabolism and Pharmacokinetics (DMPK) Services
• Other Pharmaceutical Services
Based on Process, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2019-2030 included in each section.
• Target Selection
• Target Validation
• Hit-To-Lead Identification
• Lead Optimization
• Candidate Validation
Based on Technology, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2019-2030 included in each section.
• High Throughput Screening
• Combinatorial Chemistry
• Pharmacogenomics and Pharmacogenetics
• Nanotechnology
• Bioanalytical Instruments
• Biochips
• Bioinformatics
• Other Technologies
Based on Therapeutic Area, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2019-2030 included in each section.
• Oncology
• Neurology
• Infectious and Immune System Diseases
• Digestive System Diseases
• Cardiovascular Diseases
• Diabetes
• Respiratory Disease
• Other Therapeutic Areas
Based on End User, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2019-2030 included in each section.
• Pharmaceutical Companies
• Contract Research Organizations (CROs)
• Research Institutes
• Other End Users
Geographically, the following regions together with the listed national/local markets are fully investigated:
• North America (U.S., Canada, and Mexico)
• Europe (Germany, UK, France, Spain, Italy, Russia, Rest of Europe; Rest of Europe is further segmented into Netherlands, Switzerland, Poland, Sweden, Belgium, Austria, Ireland, Norway, Denmark, and Finland)
• APAC (Japan, China, South Korea, Australia, India, and Rest of APAC; Rest of APAC is further segmented into Malaysia, Singapore, Indonesia, Thailand, New Zealand, Vietnam, Taiwan, and Philippines)
• South America (Brazil, Chile, Argentina, Rest of South America)
• MEA (UAE, Saudi Arabia, South Africa)
For each aforementioned region and country, detailed analysis and data for annual revenue ($ mn) are available for 2019-2030. The breakdown of all regional markets by country and split of key national markets by Drug Type, Service, and Therapeutic Area over the forecast years are also included.
The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.
Key Players (this may not be a complete list and extra companies can be added upon request):
Abbott Laboratories Inc.
Agilent Technologies Inc.
Astrazeneca plc
Bayer AG
Charles River Laboratories International Inc.
Eli Lilly and Company
F. Hoffmann-La Roche Ltd
GlaxoSmithKline PLC
Merck & Co. Inc.
Novartis AG
Pfizer Inc.
Shimadzu Corp
Thermo Fisher Scientific Inc.
(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
1 Introduction 10
1.1 Industry Definition and Research Scope 10
1.1.1 Industry Definition 10
1.1.2 Research Scope 11
1.2 Research Methodology 14
1.2.1 Overview of Market Research Methodology 14
1.2.2 Market Assumption 15
1.2.3 Secondary Data 15
1.2.4 Primary Data 15
1.2.5 Data Filtration and Model Design 16
1.2.6 Market Size/Share Estimation 17
1.2.7 Research Limitations 18
1.3 Executive Summary 19
2 Market Overview and Dynamics 22
2.1 Market Size and Forecast 22
2.1.1 Impact of COVID-19 on World Economy 23
2.1.2 Impact of COVID-19 on the Market 26
2.2 Major Growth Drivers 28
2.3 Market Restraints and Challenges 35
2.4 Emerging Opportunities and Market Trends 38
2.5 Porter’s Fiver Forces Analysis 42
3 Segmentation of Global Market by Drug Type 46
3.1 Market Overview by Drug Type 46
3.2 Small Molecule Drugs 48
3.3 Biologic Drugs 49
4 Segmentation of Global Market by Service 50
4.1 Market Overview by Service 50
4.2 Medicinal Chemical Services 52
4.3 Biological Services 53
4.4 Drug Metabolism and Pharmacokinetics (DMPK) Services 54
4.5 Other Pharmaceutical Services 55
5 Segmentation of Global Market by Process 56
5.1 Market Overview by Process 56
5.2 Target Selection 58
5.3 Target Validation 59
5.4 Hit-To-Lead Identification 60
5.5 Lead Optimization 61
5.6 Candidate Validation 62
6 Segmentation of Global Market by Technology 63
6.1 Market Overview by Technology 63
6.2 High Throughput Screening 65
6.3 Combinatorial Chemistry 66
6.4 Pharmacogenomics and Pharmacogenetics 67
6.5 Nanotechnology 68
6.6 Bioanalytical Instruments 69
6.7 Biochips 70
6.8 Bioinformatics 71
6.9 Other Technologies 72
7 Segmentation of Global Market by Therapeutic Area 73
7.1 Market Overview by Therapeutic Area 73
7.2 Oncology 75
7.3 Neurology 76
7.4 Infectious and Immune System Diseases 77
7.5 Digestive System Diseases 78
7.6 Cardiovascular Diseases 79
7.7 Diabetes 80
7.8 Respiratory Disease 81
7.9 Other Therapeutic Areas 82
8 Segmentation of Global Market by End User 83
8.1 Market Overview by End User 83
8.2 Pharmaceutical Companies 85
8.3 Contract Research Organizations (CROs) 86
8.4 Research Institutes 87
8.5 Other End Users 88
9 Segmentation of Global Market by Region 89
9.1 Geographic Market Overview 2019-2030 89
9.2 North America Market 2019-2030 by Country 94
9.2.1 Overview of North America Market 94
9.2.2 U.S. 98
9.2.3 Canada 104
9.2.4 Mexico 106
9.3 European Market 2019-2030 by Country 108
9.3.1 Overview of European Market 108
9.3.2 Germany 112
9.3.3 U.K. 114
9.3.4 France 116
9.3.5 Spain 118
9.3.6 Italy 120
9.3.7 Russia 122
9.3.8 Rest of European Market 124
9.4 Asia-Pacific Market 2019-2030 by Country 126
9.4.1 Overview of Asia-Pacific Market 126
9.4.2 Japan 130
9.4.3 China 133
9.4.4 Australia 135
9.4.5 India 137
9.4.6 South Korea 139
9.4.7 Rest of APAC Region 141
9.5 South America Market 2019-2030 by Country 143
9.5.1 Argentina 146
9.5.2 Brazil 148
9.5.3 Chile 150
9.5.4 Rest of South America Market 152
9.6 MEA Market 2019-2030 by Country 153
9.6.1 UAE 156
9.6.2 Saudi Arabia 158
9.6.3 South Africa 160
9.6.4 Other National Markets 162
10 Competitive Landscape 163
10.1 Overview of Key Vendors 163
10.2 New Product Launch, Partnership, Investment, and M&A 166
10.3 Company Profiles 167
Abbott Laboratories Inc. 167
Agilent Technologies Inc. 169
Astrazeneca plc 170
Bayer AG 171
Charles River Laboratories International Inc. 172
Eli Lilly and Company 173
F. Hoffmann-La Roche Ltd 174
GlaxoSmithKline PLC 175
Merck & Co. Inc. 176
Novartis AG 177
Pfizer Inc. 178
Shimadzu Corp 179
Thermo Fisher Scientific Inc. 180
RELATED REPORTS 181
List of Tables:
Table 1. Snapshot of Global Drug Discovery Market in Balanced Perspective, 2019-2030 20
Table 2. Growth Rate of World GDP, 2020-2022 24
Table 3. World Top 10 Pharmaceutical Companies Based on Projected R&D Spending in 2026, $ bn 30
Table 4. World Health Spending by Region, $ bn, 2013-2020 33
Table 5. Total Number of Registered Clinical Studies Worldwide, 2010-2019 34
Table 6. Main Product Trends and Market Opportunities in Global Drug Discovery Market 38
Table 7. Global Drug Discovery Market by Drug Type, 2019-2030, $ mn 46
Table 8. Global Drug Discovery Market by Service, 2019-2030, $ mn 50
Table 9. Global Drug Discovery Market by Process, 2019-2030, $ mn 56
Table 10. Global Drug Discovery Market by Technology, 2019-2030, $ mn 63
Table 11. Global Drug Discovery Market by Therapeutic Area, 2019-2030, $ mn 73
Table 12. Global Drug Discovery Market by End User, 2019-2030, $ mn 83
Table 13. Global Drug Discovery Market by Region, 2019-2030, $ mn 90
Table 14. Leading National Drug Discovery Market, 2019 and 2030F, $ mn 92
Table 15. North America Drug Discovery Market by Country, 2019-2030, $ mn 96
Table 16. U.S. Drug Discovery Market by Drug Type, 2019-2030, $ mn 100
Table 17. U.S. Drug Discovery Market by Service, 2019-2030, $ mn 100
Table 18. U.S. Drug Discovery Market by Therapeutic Area, 2019-2030, $ mn 100
Table 19. Novel Drug Approvals in U.S. in 2020 101
Table 20. Canada Drug Discovery Market by Drug Type, 2019-2030, $ mn 105
Table 21. Canada Drug Discovery Market by Service, 2019-2030, $ mn 105
Table 22. Canada Drug Discovery Market by Therapeutic Area, 2019-2030, $ mn 105
Table 23. Mexico Drug Discovery Market by Drug Type, 2019-2030, $ mn 107
Table 24. Mexico Drug Discovery Market by Service, 2019-2030, $ mn 107
Table 25. Mexico Drug Discovery Market by Therapeutic Area, 2019-2030, $ mn 107
Table 26. Europe Drug Discovery Market by Country, 2019-2030, $ mn 111
Table 27. Germany Drug Discovery Market by Drug Type, 2019-2030, $ mn 113
Table 28. Germany Drug Discovery Market by Service, 2019-2030, $ mn 113
Table 29. Germany Drug Discovery Market by Therapeutic Area, 2019-2030, $ mn 113
Table 30. U.K. Drug Discovery Market by Drug Type, 2019-2030, $ mn 115
Table 31. U.K. Drug Discovery Market by Service, 2019-2030, $ mn 115
Table 32. U.K. Drug Discovery Market by Therapeutic Area, 2019-2030, $ mn 115
Table 33. France Drug Discovery Market by Drug Type, 2019-2030, $ mn 117
Table 34. France Drug Discovery Market by Service, 2019-2030, $ mn 117
Table 35. France Drug Discovery Market by Therapeutic Area, 2019-2030, $ mn 117
Table 36. Spain Drug Discovery Market by Drug Type, 2019-2030, $ mn 119
Table 37. Spain Drug Discovery Market by Service, 2019-2030, $ mn 119
Table 38. Spain Drug Discovery Market by Therapeutic Area, 2019-2030, $ mn 119
Table 39. Italy Drug Discovery Market by Drug Type, 2019-2030, $ mn 121
Table 40. Italy Drug Discovery Market by Service, 2019-2030, $ mn 121
Table 41. Italy Drug Discovery Market by Therapeutic Area, 2019-2030, $ mn 121
Table 42. Russia Drug Discovery Market by Drug Type, 2019-2030, $ mn 123
Table 43. Russia Drug Discovery Market by Service, 2019-2030, $ mn 123
Table 44. Russia Drug Discovery Market by Therapeutic Area, 2019-2030, $ mn 123
Table 45. Drug Discovery Market in Rest of Europe by Country, 2019-2030, $ mn 125
Table 46. APAC Drug Discovery Market by Country, 2019-2030, $ mn 128
Table 47. Japan Drug Discovery Market by Drug Type, 2019-2030, $ mn 132
Table 48. Japan Drug Discovery Market by Service, 2019-2030, $ mn 132
Table 49. Japan Drug Discovery Market by Therapeutic Area, 2019-2030, $ mn 132
Table 50. China Drug Discovery Market by Drug Type, 2019-2030, $ mn 134
Table 51. China Drug Discovery Market by Service, 2019-2030, $ mn 134
Table 52. China Drug Discovery Market by Therapeutic Area, 2019-2030, $ mn 134
Table 53. Australia Drug Discovery Market by Drug Type, 2019-2030, $ mn 136
Table 54. Australia Drug Discovery Market by Service, 2019-2030, $ mn 136
Table 55. Australia Drug Discovery Market by Therapeutic Area, 2019-2030, $ mn 136
Table 56. India Drug Discovery Market by Drug Type, 2019-2030, $ mn 138
Table 57. India Drug Discovery Market by Service, 2019-2030, $ mn 138
Table 58. India Drug Discovery Market by Therapeutic Area, 2019-2030, $ mn 138
Table 59. South Korea Drug Discovery Market by Drug Type, 2019-2030, $ mn 140
Table 60. South Korea Drug Discovery Market by Service, 2019-2030, $ mn 140
Table 61. South Korea Drug Discovery Market by Therapeutic Area, 2019-2030, $ mn 140
Table 62. Drug Discovery Market in Rest of APAC by Country/Region, 2019-2030, $ mn 142
Table 63. South America Drug Discovery Market by Country, 2019-2030, $ mn 145
Table 64. Argentina Drug Discovery Market by Drug Type, 2019-2030, $ mn 147
Table 65. Argentina Drug Discovery Market by Service, 2019-2030, $ mn 147
Table 66. Argentina Drug Discovery Market by Therapeutic Area, 2019-2030, $ mn 147
Table 67. Brazil Drug Discovery Market by Drug Type, 2019-2030, $ mn 149
Table 68. Brazil Drug Discovery Market by Service, 2019-2030, $ mn 149
Table 69. Brazil Drug Discovery Market by Therapeutic Area, 2019-2030, $ mn 149
Table 70. Chile Drug Discovery Market by Drug Type, 2019-2030, $ mn 151
Table 71. Chile Drug Discovery Market by Service, 2019-2030, $ mn 151
Table 72. Chile Drug Discovery Market by Therapeutic Area, 2019-2030, $ mn 151
Table 73. MEA Drug Discovery Market by Country, 2019-2030, $ mn 155
Table 74. UAE Drug Discovery Market by Drug Type, 2019-2030, $ mn 157
Table 75. UAE Drug Discovery Market by Service, 2019-2030, $ mn 157
Table 76. UAE Drug Discovery Market by Therapeutic Area, 2019-2030, $ mn 157
Table 77. Saudi Arabia Drug Discovery Market by Drug Type, 2019-2030, $ mn 159
Table 78. Saudi Arabia Drug Discovery Market by Service, 2019-2030, $ mn 159
Table 79. Saudi Arabia Drug Discovery Market by Therapeutic Area, 2019-2030, $ mn 159
Table 80. South Africa Drug Discovery Market by Drug Type, 2019-2030, $ mn 161
Table 81. South Africa Drug Discovery Market by Service, 2019-2030, $ mn 161
Table 82. South Africa Drug Discovery Market by Therapeutic Area, 2019-2030, $ mn 161
Table 83. Abbott Laboratories Inc.: Company Snapshot 167
Table 84. Abbott Laboratories Inc.: Business Segmentation 167
Table 85. Abbott Laboratories Inc.: Product Portfolio 168
Table 86. Abbott Laboratories Inc.: Revenue, 2018-2020, $ mn 168
List of Figures:
Figure 1. Research Method Flow Chart 14
Figure 2. Bottom-up Approach and Top-down Approach for Market Estimation 17
Figure 3. Global Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2019-2030 19
Figure 4. Global Drug Discovery Market, 2019-2030, $ mn 22
Figure 5. Impact of COVID-19 on Business 26
Figure 6. Primary Drivers and Impact Factors of Global Drug Discovery Market 28
Figure 7. Worldwide Geriatric Population (60 years and above) by Regions, 2015 & 2030, million 32
Figure 8. World Population 65 and Over, % of Total Population, 1950-2060 32
Figure 9. Primary Restraints and Impact Factors of Global Drug Discovery Market 35
Figure 10. Investment Opportunity Analysis 39
Figure 11. Porter’s Fiver Forces Analysis of Global Drug Discovery Market 42
Figure 12. Breakdown of Global Drug Discovery Market by Drug Type, 2019-2030, % of Revenue 47
Figure 13. Global Addressable Market Cap in 2021-2030 by Drug Type, Value ($ mn) and Share (%) 47
Figure 14. Global Drug Discovery Market by Drug Type: Small Molecule Drugs, 2019-2030, $ mn 48
Figure 15. Global Drug Discovery Market by Drug Type: Biologic Drugs, 2019-2030, $ mn 49
Figure 16. Breakdown of Global Drug Discovery Market by Service, 2019-2030, % of Sales Revenue 51
Figure 17. Global Addressable Market Cap in 2021-2030 by Service, Value ($ mn) and Share (%) 51
Figure 18. Global Drug Discovery Market by Service: Medicinal Chemical Services, 2019-2030, $ mn 52
Figure 19. Global Drug Discovery Market by Service: Biological Services, 2019-2030, $ mn 53
Figure 20. Global Drug Discovery Market by Service: Drug Metabolism and Pharmacokinetics (DMPK) Services, 2019-2030, $ mn 54
Figure 21. Global Drug Discovery Market by Service: Other Pharmaceutical Services, 2019-2030, $ mn 55
Figure 22. Breakdown of Global Drug Discovery Market by Process, 2019-2030, % of Sales Revenue 57
Figure 23. Global Addressable Market Cap in 2021-2030 by Process, Value ($ mn) and Share (%) 57
Figure 24. Global Drug Discovery Market by Process: Target Selection, 2019-2030, $ mn 58
Figure 25. Global Drug Discovery Market by Process: Target Validation, 2019-2030, $ mn 59
Figure 26. Global Drug Discovery Market by Process: Hit-To-Lead Identification, 2019-2030, $ mn 60
Figure 27. Global Drug Discovery Market by Process: Lead Optimization, 2019-2030, $ mn 61
Figure 28. Global Drug Discovery Market by Process: Candidate Validation, 2019-2030, $ mn 62
Figure 29. Breakdown of Global Drug Discovery Market by Technology, 2019-2030, % of Revenue 64
Figure 30. Global Addressable Market Cap in 2021-2030 by Technology, Value ($ mn) and Share (%) 64
Figure 31. Global Drug Discovery Market by Technology: High Throughput Screening, 2019-2030, $ mn 65
Figure 32. Global Drug Discovery Market by Technology: Combinatorial Chemistry, 2019-2030, $ mn 66
Figure 33. Global Drug Discovery Market by Technology: Pharmacogenomics and Pharmacogenetics, 2019-2030, $ mn 67
Figure 34. Global Drug Discovery Market by Technology: Nanotechnology, 2019-2030, $ mn 68
Figure 35. Global Drug Discovery Market by Technology: Bioanalytical Instruments, 2019-2030, $ mn 69
Figure 36. Global Drug Discovery Market by Technology: Biochips, 2019-2030, $ mn 70
Figure 37. Global Drug Discovery Market by Technology: Bioinformatics, 2019-2030, $ mn 71
Figure 38. Global Drug Discovery Market by Technology: Other Technologies, 2019-2030, $ mn 72
Figure 39. Breakdown of Global Drug Discovery Market by Therapeutic Area, 2019-2030, % of Revenue 74
Figure 40. Global Addressable Market Cap in 2021-2030 by Therapeutic Area, Value ($ mn) and Share (%) 74
Figure 41. Global Drug Discovery Market by Therapeutic Area: Oncology, 2019-2030, $ mn 75
Figure 42. Global Drug Discovery Market by Therapeutic Area: Neurology, 2019-2030, $ mn 76
Figure 43. Global Drug Discovery Market by Therapeutic Area: Infectious and Immune System Diseases, 2019-2030, $ mn 77
Figure 44. Global Drug Discovery Market by Therapeutic Area: Digestive System Diseases, 2019-2030, $ mn 78
Figure 45. Global Drug Discovery Market by Therapeutic Area: Cardiovascular Diseases, 2019-2030, $ mn 79
Figure 46. Global Drug Discovery Market by Therapeutic Area: Diabetes, 2019-2030, $ mn 80
Figure 47. Global Drug Discovery Market by Therapeutic Area: Respiratory Disease, 2019-2030, $ mn 81
Figure 48. Global Drug Discovery Market by Therapeutic Area: Other Therapeutic Areas, 2019-2030, $ mn 82
Figure 49. Breakdown of Global Drug Discovery Market by End User, 2019-2030, % of Revenue 83
Figure 50. Global Addressable Market Cap in 2021-2030 by End User, Value ($ mn) and Share (%) 84
Figure 51. Global Drug Discovery Market by End User: Pharmaceutical Companies, 2019-2030, $ mn 85
Figure 52. Global Drug Discovery Market by End User: Contract Research Organizations (CROs), 2019-2030, $ mn 86
Figure 53. Global Drug Discovery Market by End User: Research Institutes, 2019-2030, $ mn 87
Figure 54. Global Drug Discovery Market by End User: Other End Users, 2019-2030, $ mn 88
Figure 55. Global Market Snapshot by Region 89
Figure 56. Geographic Spread of Worldwide Drug Discovery Market, 2019-2030, % of Sales Revenue 90
Figure 57. Global Addressable Market Cap in 2021-2030 by Region, Value ($ mn) and Share (%) 91
Figure 58. Health Spending as a Share of GDP by Country, 2015 and 2030 93
Figure 59. North American Drug Discovery Market, 2019-2030, $ mn 95
Figure 60. Breakdown of North America Drug Discovery Market by Country, 2019 and 2030, % of Revenue 96
Figure 61. Contribution to North America 2021-2030 Cumulative Market by Country, Value ($ mn) and Share (%) 97
Figure 62. U.S. Drug Discovery Market, 2019-2030, $ mn 99
Figure 63. Canada Drug Discovery Market, 2019-2030, $ mn 104
Figure 64. Drug Discovery Market in Mexico, 2019-2030, $ mn 106
Figure 65. European Drug Discovery Market, 2019-2030, $ mn 109
Figure 66. Breakdown of European Drug Discovery Market by Country, 2019 and 2030, % of Revenue 110
Figure 67. Contribution to Europe 2021-2030 Cumulative Market by Country, Value ($ mn) and Share (%) 111
Figure 68. Drug Discovery Market in Germany, 2019-2030, $ mn 112
Figure 69. Drug Discovery Market in U.K., 2019-2030, $ mn 114
Figure 70. Drug Discovery Market in France, 2019-2030, $ mn 116
Figure 71. Drug Discovery Market in Spain, 2019-2030, $ mn 118
Figure 72. Drug Discovery Market in Italy, 2019-2030, $ mn 120
Figure 73. Drug Discovery Market in Russia, 2019-2030, $ mn 122
Figure 74. Drug Discovery Market in Rest of Europe, 2019-2030, $ mn 124
Figure 75. Asia-Pacific Drug Discovery Market, 2019-2030, $ mn 127
Figure 76. Breakdown of APAC Drug Discovery Market by Country, 2019 and 2030, % of Revenue 127
Figure 77. Contribution to APAC 2021-2030 Cumulative Market by Country, Value ($ mn) and Share (%) 129
Figure 78. Drug Discovery Market in Japan, 2019-2030, $ mn 131
Figure 79. Drug Discovery Market in China, 2019-2030, $ mn 133
Figure 80. Drug Discovery Market in Australia, 2019-2030, $ mn 135
Figure 81. Drug Discovery Market in India, 2019-2030, $ mn 137
Figure 82. Drug Discovery Market in South Korea, 2019-2030, $ mn 139
Figure 83. Drug Discovery Market in Rest of APAC, 2019-2030, $ mn 141
Figure 84. South America Drug Discovery Market, 2019-2030, $ mn 144
Figure 85. Breakdown of South America Drug Discovery Market by Country, 2019 and 2030, % of Revenue 144
Figure 86. Contribution to South America 2021-2030 Cumulative Market by Country, Value ($ mn) and Share (%) 145
Figure 87. Drug Discovery Market in Argentina, 2019-2030, $ mn 146
Figure 88. Drug Discovery Market in Brazil, 2019-2030, $ mn 148
Figure 89. Drug Discovery Market in Chile, 2019-2030, $ mn 150
Figure 90. Drug Discovery Market in Rest of South America, 2019-2030, $ mn 152
Figure 91. Drug Discovery Market in Middle East and Africa (MEA), 2019-2030, $ mn 154
Figure 92. Breakdown of MEA Drug Discovery Market by Country, 2019 and 2030, % of Revenue 154
Figure 93. Contribution to MEA 2021-2030 Cumulative Market by Country, Value ($ mn) and Share (%) 155
Figure 94. Drug Discovery Market in UAE, 2019-2030, $ mn 156
Figure 95. Drug Discovery Market in Saudi Arabia, 2019-2030, $ mn 158
Figure 96. Drug Discovery Market in South Africa, 2019-2030, $ mn 160
Figure 97. Growth Stage of Global Drug Discovery Industry over the Forecast Period 163